# Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer

> **NCT00002474** · PHASE2 · COMPLETED · sponsor: **Loyola University**

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** mitoxantrone hydrochloride
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** bone marrow ablation with stem cell support

## Key facts

- **NCT ID:** NCT00002474
- **Lead sponsor:** Loyola University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-02
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002474, "Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00002474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*